A Conserved Rad6-Mdm2 Ubiquitin Ligase Machinery Targets Histone Chaperone Asf1a in Tumorigenesis

Chen Wang,Jian-Feng Chang,Hongli Yan,Da-Liang Wang,Yan Liu,Yuanya Jing,Meng Zhang,Yu-Long Men,Dongdong Lu,Xiao-Mei Yang,Su Chen,Fang-Lin Sun
DOI: https://doi.org/10.18632/oncotarget.5011
2015-01-01
Oncotarget
Abstract:Chromatin is a highly organized and dynamic structure in eukaryotic cells. The change of chromatin structure is essential in many cellular processes, such as gene transcription, DNA damage repair and others. Anti-silencing function 1 (ASF1) is a histone chaperone that participates in chromatin higher-order organization and is required for appropriate chromatin assembly. In this study, we identified the E2 ubiquitin-conjugating enzyme RAD6 as an evolutionary conserved interacting protein of ASF1 in D. melanogaster and H. sapiens that promotes the turnover of ASF1A by cooperating with a well-known E3 ligase, MDM2, via ubiquitin-proteasome pathway in H. sapiens. Further functional analyses indicated that the interplay between RAD6 and ASF1A associates with tumorigenesis. Together, these data suggest that the RAD6-MDM2 ubiquitin ligase machinery is critical for the degradation of chromatin-related proteins.
What problem does this paper attempt to address?